Background:
Laparoscopic cholecystectomy (LC) has been associated with an increase in the incidence of biliary and vascular injuries. Pseudoaneurysms (PAs) following LC are rare life-threatening events with limited available experience regarding diagnosis and treatment.
Materials and Methods:
An extensive review of literature during a 26-year period (1994–2020) using MEDLINE
®
database and Google Scholar
®
academic search engine revealed 134 patients with at least one symptomatic PA following LC.
Results:
Nearly 81% of patients with PAs become symptomatic during the first 8 weeks following LC. The most common symptoms were gastrointestinal bleeding (74%) and abdominal pain (61%). In 28% of cases, there was a concomitant bile duct injury or leak from the cystic duct stump, whereas in about one-third of cases, PAs presented following an uneventful LC. The most common involved arteries were the right hepatic artery (70%), the cystic artery (19%) or both of them (3%). Trans-arterial embolisation was the favoured first-line treatment with a success rate of 83%. During a median follow-up of 9 months, the mortality rate was 7%.
Conclusion:
Clinicians should be aware of the PA occurrence following LC. Prompt diagnosis and treatment are essential.
Introduction: Sleeve gastrectomy (SG) is currently the most commonly performed bariatric procedure worldwide. The aim of the present study was to evaluate the long-term e cacy of SG as a stand-alone bariatric procedure.Methods: A single center retrospective analysis of 104 patients who underwent SG as a stand-alone bariatric procedure between January 2005 and December 2009. Weight loss, weight regain, remission or improvement of comorbidities, and the new onset of comorbidities were the main outcomes of the study.Results: At a mean follow-up of 13.4 years, % excess body weight loss (%EBWL), % excess BMI loss (%EBMIL) and % total body weight loss (%TBWL) were 59 ± 25, 69 ± 29 and 29 ± 12, respectively. Approximately two third of patients (67.3%) maintained an %EBWL of > 50 at the last follow-up. The percentage of patients who experienced signi cant weight regain ranged from 47% to 64%, depending on the de nition used for weight regain. The rate of improvement or remission of hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea and degenerative joint disease at a mean follow-up of 13.4 years was 40%, 94.7%, 70%, 100% and 42.9%, respectively. The new onset of gastroesophageal re ux disease (GERD) in the same period was 43%. Conclusion: Our data support that SG results in long-lasting weight loss in the majority of patients and acceptable rates of remission or improvement of comorbidities. Weight regain and GERD may be issues of particular concern during long-term follow-up after SG.
Introduction: Sleeve gastrectomy (SG) is currently the most commonly performed bariatric procedure worldwide. The aim of the present study was to evaluate the long-term efficacy of SG as a stand-alone bariatric procedure.Methods: A single center retrospective analysis of 104 patients who underwent SG as a stand-alone bariatric procedure between January 2005 and December 2009. Weight loss, weight regain, remission or improvement of comorbidities, and the new onset of comorbidities were the main outcomes of the study.Results: At a mean follow-up of 13.4 years, % excess body weight loss (%EBWL), % excess BMI loss (%EBMIL) and % total body weight loss (%TBWL) were 59 ± 25, 69 ± 29 and 29 ± 12, respectively. Approximately two third of patients (67.3%) maintained an %EBWL of > 50 at the last follow-up. The percentage of patients who experienced significant weight regain ranged from 47% to 64%, depending on the definition used for weight regain. The rate of improvement or remission of hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea and degenerative joint disease at a mean follow-up of 13.4 years was 40%, 94.7%, 70%, 100% and 42.9%, respectively. The new onset of gastroesophageal reflux disease (GERD) in the same period was 43%.Conclusion: Our data support that SG results in long-lasting weight loss in the majority of patients and acceptable rates of remission or improvement of comorbidities. Weight regain and GERD may be issues of particular concern during long-term follow-up after SG.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.